相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Risk prediction models for dementia: role of age and cardiometabolic risk factors
Aurore Fayosse et al.
BMC MEDICINE (2020)
Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis
Mengshi Zhou et al.
PLOS ONE (2020)
Therapeutic Potential of TNF-α Inhibition for Alzheimer's Disease Prevention
Noel Torres-Acosta et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride
Elisabetta Patorno et al.
DIABETES CARE (2019)
Getting to the Heart of Alzheimer Disease
Joshua M. Tublin et al.
CIRCULATION RESEARCH (2019)
Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research
Konstantina G. Yiannopoulou et al.
BIOMEDICINES (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Measuring Frailty in Medicare Data: Development and Validation of a Claims-Based Frailty Index
Dae Hyun Kim et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2018)
Use of Health Care Databases to Support Supplemental Indications of Approved Medications
Michael Fralick et al.
JAMA INTERNAL MEDICINE (2018)
Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making
Marc L. Berger et al.
VALUE IN HEALTH (2017)
Understanding mechanisms and seeking cures for Alzheimer's disease: why we must be extraordinarily diverse
Madhav Thambisetty
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2017)
Introduction to the Analysis of Survival Data in the Presence of Competing Risks
Peter C. Austin et al.
CIRCULATION (2016)
Treatment for Rheumatoid Arthritis and Risk of Alzheimer's Disease: A Nested Case-Control Analysis
Richard C. Chou et al.
CNS DRUGS (2016)
Interleukin-6 Blockade as Rescue Therapy in Autoimmune Encephalitis
Russell C. Dale
NEUROTHERAPEUTICS (2016)
Therapeutic strategies for Alzheimer's disease in clinical trials
Justyna Godyn et al.
PHARMACOLOGICAL REPORTS (2016)
Sex based subgroup differences in randomized controlled trials: empirical evidence from Cochrane meta-analyses
Joshua D. Wallach et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Sex based subgroup differences in randomized controlled trials: empirical evidence from Cochrane meta-analyses
Joshua D. Wallach et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Aggression behaviour induced by oral administration of the Janus-kinase inhibitor tofacitinib, but not oclacitinib, under stressful conditions
Tomoki Fukuyama et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Active-comparator design and new-user design in observational studies
Kazuki Yoshida et al.
NATURE REVIEWS RHEUMATOLOGY (2015)
Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial
Joseph Butchart et al.
NEUROLOGY (2015)
Development and validation of a brief dementia screening indicator for primary care
Deborah E. Barnes et al.
ALZHEIMERS & DEMENTIA (2014)
The complexities of the pathology-pathogenesis relationship in Alzheimer disease
Rudy J. Castellani et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Alzheimer disease therapeutics: Focus on the disease and not just plaques and tangles
Khalid Iqbal et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?
Francesco Panza et al.
CURRENT OPINION IN PSYCHIATRY (2014)
Microglial priming in neurodegenerative disease
V. Hugh Perry et al.
NATURE REVIEWS NEUROLOGY (2014)
Metrics for covariate balance in cohort studies of causal effects
Jessica M. Franklin et al.
STATISTICS IN MEDICINE (2014)
Alzheimer's disease drug-development pipeline: few candidates, frequent failures
Jeffrey L. Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Alzheimer disease in the United States (2010-2050) estimated using the 2010 census
Liesi E. Hebert et al.
NEUROLOGY (2013)
Endotoxin-induced systemic inflammation activates microglia: [11C]PBR28 positron emission tomography in nonhuman primates
Jonas Hannestad et al.
NEUROIMAGE (2012)
One-to-many propensity score matching in cohort studies
Jeremy A. Rassen et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
A basic study design for expedited safety signal evaluation based on electronic healthcare data
Sebastian Schneeweiss
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
The Accuracy of Medicare Claims as an Epidemiological Tool: The Case of Dementia Revisited
Donald H. Taylor et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
TNF-α inhibition as a treatment strategy for neurodegenerative disorders:: New drug candidates and targets
David Tweedie et al.
CURRENT ALZHEIMER RESEARCH (2007)
Adherence to lipid-lowering therapy and the use of preventive health services: An investigation of the healthy user effect
M. Alan Brookhart et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study
Miia Kivipelto et al.
LANCET NEUROLOGY (2006)
Neuropathology of older persons without cognitive impairment from two community-based studies
D. A. Bennett et al.
NEUROLOGY (2006)
Evaluating medication effects outside of clinical trials: New-user designs
WA Ray
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data
S Schneeweiss et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2001)
分享论文
